Tuesday Mar 4
IMS Health Incorporated - Strategic SWOT Analysis Review - New Market Study Published
Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations.
IGI Laboratories, Inc. Announces Fourteenth ANDA Submission
IGI Laboratories, Inc. , a New Jersey based generic topical pharmaceutical company, today announced it has submitted its first abbreviated new drug application in 2014 to the U.S. Food and Drug Administration , which brings the Company's total number of ANDA submissions to fourteen.